Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model
Overview
Authors
Affiliations
Background: Marfan syndrome (MF) leads to aortic root dilatation and a predisposition to aortic dissection, mitral valve prolapse, and primary and secondary cardiomyopathy. Overall, regular physical exercise is recommended for a healthy lifestyle, but dynamic sports are strongly discouraged in MF patients. Nonetheless, evidence supporting this recommendation is lacking. Therefore, we studied the role of long-term dynamic exercise of moderate intensity on the MF cardiovascular phenotype.
Methods And Results: In a transgenic mouse model of MF (), 4-month-old wild-type and MF mice were subjected to training on a treadmill for 5 months; sedentary littermates served as controls for each group. Aortic and cardiac remodeling was assessed by echocardiography and histology. The 4-month-old MF mice showed aortic root dilatation, elastic lamina rupture, and tunica media fibrosis, as well as cardiac hypertrophy, left ventricular fibrosis, and intramyocardial vessel remodeling. Over the 5-month experimental period, aortic root dilation rate was significantly greater in the sedentary MF group, compared with the wild-type group (∆mm, 0.27±0.07 versus 0.13±0.02, respectively). Exercise significantly blunted the aortic root dilation rate in MF mice compared with sedentary MF littermates (∆mm, 0.10±0.04 versus 0.27±0.07, respectively). However, these 2 groups were indistinguishable by aortic root stiffness, tunica media fibrosis, and elastic lamina ruptures. In MF mice, exercise also produced cardiac hypertrophy regression without changes in left ventricular fibrosis.
Conclusions: Our results in a transgenic mouse model of MF indicate that moderate dynamic exercise mitigates the progression of the MF cardiovascular phenotype.
Stiefel M, Brito da Silva H, Schmied C, Niederseer D J Cardiovasc Dev Dis. 2024; 11(12).
PMID: 39728269 PMC: 11677462. DOI: 10.3390/jcdd11120379.
Meccanici F, Roos-Hesselink J Int J Cardiol Congenit Heart Dis. 2024; 10:100412.
PMID: 39713595 PMC: 11657548. DOI: 10.1016/j.ijcchd.2022.100412.
Jouini S, Milleron O, Eliahou L, Jondeau G, Vitiello D J Am Heart Assoc. 2024; 13(19):e033024.
PMID: 39291498 PMC: 11681478. DOI: 10.1161/JAHA.123.033024.
Management of aortic disease in children with FBN1-related Marfan syndrome.
Muino-Mosquera L, Cervi E, De Groote K, Dewals W, Fejzic Z, Kazamia K Eur Heart J. 2024; 45(39):4156-4169.
PMID: 39250726 PMC: 11472455. DOI: 10.1093/eurheartj/ehae526.
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.
PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.